Related references
Note: Only part of the references are listed.FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
Takashi Sato et al.
BLOOD (2011)
Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development
Charlotta Boiers et al.
BLOOD (2010)
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Tetsuya Mitsudomi et al.
FEBS JOURNAL (2010)
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
Jianbiao Zhou et al.
BLOOD (2009)
Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy
Rama Krishna Kancha et al.
CLINICAL CANCER RESEARCH (2009)
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
Soheil Meshinchi et al.
CLINICAL CANCER RESEARCH (2009)
Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells
Junichi Soh et al.
PLOS ONE (2009)
Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model
Li Li et al.
BLOOD (2008)
Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia
Manoj Raghavan et al.
BLOOD (2008)
Modeling of C/EBP alpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells
Peggy Kirstetter et al.
CANCER CELL (2008)
Abnormal localization and accumulation of FLT3-ITD, a mutant receptor tyrosine kinase involved in leukemogenesis
Sina Koch et al.
CELLS TISSUES ORGANS (2008)
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression
Lei L. Chen et al.
MODERN PATHOLOGY (2008)
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
Rosemary E. Gale et al.
BLOOD (2008)
A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy
N. Nakai et al.
JOURNAL OF PATHOLOGY (2008)
Critical role of FLT3 ligand in IL-7 receptor-independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors
Ewa Sitnicka et al.
BLOOD (2007)
Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy
Cornelis J. H. Pronk et al.
CELL STEM CELL (2007)
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia
Benjamin H. Lee et al.
CANCER CELL (2007)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
J Fitzgibbon et al.
CANCER RESEARCH (2005)
A knock-in mouse model of gastrointestinal stromal tumor harboring Kit K641E
BP Rubin et al.
CANCER RESEARCH (2005)
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
MJ Kiel et al.
CELL (2005)
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
C Choudhary et al.
BLOOD (2005)
Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases
DE Schmidt-Arras et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential:: A revised road map for adult blood lineage commitment
J Adolfsson et al.
CELL (2005)
Enforced expression of cyclin D2 enhances the proliferative potential of myeloid progenitors, accelerates in vivo myeloid reconstitution, and promotes rescue of mice from lethal myeloablation
Y Sasaki et al.
BLOOD (2004)
Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
C Graveel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells
R Zheng et al.
BLOOD (2004)
A gain of function mutation in the activation loop of platelet-derived growth factor β-receptor deregulates its kinase activity
F Chiara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
S Schnittger et al.
BLOOD (2002)
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
M Levis et al.
BLOOD (2002)
Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML
K Deguchi et al.
LEUKEMIA (2002)
Loss of heterozygosity at the RET protooncogene locus in a case of multiple endocrine neoplasia type 2A
L Quadro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B
CL Smith-Hicks et al.
EMBO JOURNAL (2000)
Share Paper
